Carregant...
PD-1/PD-L1 inhibitors in multiple myeloma: The present and the future
The introduction of PD-1/PD-L1 pathway inhibitors has marked a significant milestone in the treatment of various types of solid tumors. The current situation in multiple myeloma (MM) is rather unclear, as distinct research groups have reported discordant results. This discrepancy dominantly concerns...
Guardat en:
| Publicat a: | Oncoimmunology |
|---|---|
| Autors principals: | , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Taylor & Francis
2016
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5215080/ https://ncbi.nlm.nih.gov/pubmed/28123899 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/2162402X.2016.1254856 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|